We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9866:HKEXNIO Inc. Class A Analysis

Data as of 2026-05-23 - not real-time

HK$42.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

NIO’s latest quarter delivered 83,465 vehicles and generated RMB 25.5 bn in revenue, representing a 112% YoY increase, yet the stock is trading at HKD 42.78, just above the computed support of 41.88 and well below both the 20‑day (47.48) and 50‑day (47.82) SMAs. The RSI sits at 36, hinting at modest oversold pressure, while the MACD remains bearish with a widening histogram, suggesting short‑term downside momentum. Volatility is elevated at 54.9% 30‑day, but beta is low (≈0.36), indicating limited market‑wide correlation.
Valuation metrics show a forward PE of 18.6 and a price‑to‑book of 22.1, while analysts project a mean target of 56.1, implying roughly 31% upside. Despite zero dividend and a high debt‑to‑equity ratio (~183), forward EPS is positive and the consensus recommendation is “Buy.” The blend of strong revenue growth, attractive upside potential, and manageable market risk supports a medium‑term buying stance, while short‑term caution is advised due to bearish technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram indicating downward momentum
  • Price near technical support at 41.88 HKD
  • RSI approaching oversold territory at 36

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 112% YoY and strong vehicle delivery numbers
  • Analyst consensus target price offering ~31% upside
  • Forward PE of 18.6 suggesting reasonable valuation relative to earnings outlook

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Long‑term EV market tailwinds in China and expanding overseas
  • Diversified power‑services ecosystem (swap, home charging, mobile charging)
  • High leverage and negative margins require monitoring but are offset by growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth112.20%
Profit Margin-9.09%
P/E Ratio18.6
ROE-83.96%
ROA-4.42%
Debt/Equity183.30
P/B Ratio22.1

Technical Analysis

TrendNeutral
RSI36.4
SupportHK$41.88
ResistanceHK$52.90
MA 20HK$47.48
MA 50HK$47.82
MA 200HK$45.48
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Target PriceHK$56.10
Upside/Downside31.14%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.36
Volatility54.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.